APGE Apogee Therapeutics, Inc. Common Stock

Sentiment & Price 2 ideas • 1 voices • 1 sources ▼
Sentiment Gauge
0
Bull
2
Bear
0
Watch
Bull 0% Bear 100%
Price & Sentiment long short neutral — click post dots to open
Loading chart...
Recent News Top Views ▼
No recent news for APGE
No theses available
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
News✓
Loading...
All directions✓
▲ Long✓
▼ Short✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
20:33
Apr 20
A May MD Biotech investor
Short APGE due to the implied failure of its key OX40 combination drug candidate, which removes a major value catalyst and suggests underlying pipeline weakness is not fully priced in.
APGE
MED
12:59
Apr 18
A May MD Biotech investor
Short APGE as management's narrative regarding Lebrikizumab underdosing is contradicted by maintenance data showing better efficacy at lower exposure levels, indicating thesis creep and fabricated claims.
APGE
HIGH

About APGE Analyst Coverage

Buzzberg tracks APGE (Apogee Therapeutics, Inc. Common Stock) across 1 sources. 0 bullish vs 2 bearish calls from 1 analysts. Sentiment: mixed to bearish. 2 total trade ideas tracked.